Stories for Change: Digital Storytelling as a Tool for Engagement in Facilitated Discussion for Diabetes

Diabetes Mellitus Clinical Trial

Official title:

Stories for Change: Digital Storytelling as a Tool for Engagement in Facilitated Discussion for Reduction of Diabetes-Related Health Disparities

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02969954
• Other study ID #: 16-005091
• Status: Completed
• Phase: N/A
• First received: November 16, 2016
• Last updated: February 12, 2018
• Start date: November 2016
• Est. completion date: December 2017

Study information

• Verified date: February 2018
• Source: Mayo Clinic
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Racial and ethnic minorities with type II diabetes in the US are more likely to develop complications and die from the disease than the general population. The foreign-born subset of this population is less likely to adhere to diabetes care recommendations than US-born patients, thereby placing them at higher risk for complications. In our previous pilot project, eight stories were assessed through preliminary multi-site intervention for acceptability and efficacy in diabetes management among Latino and Somali patients with poorly controlled type II diabetes. The goal of this project is to evaluate a new format for delivery of a culturally tailored digital storytelling intervention by incorporating a facilitated group discussion following the videos, for management of type II diabetes in Latino communities.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 22
• Est. completion date: December 2017
• Est. primary completion date: December 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion criteria:

1. Self-identify as Hispanic/Latino

2. Are Spanish-speaking

3. Receive primary care at one of the participating clinical sites

4. Self-reported diagnosis of type II diabetes

Exclusion criteria:

1. Not able to give informed consent

2. Not able to participate in a group discussion

Related Conditions & MeSH terms

• Diabetes Mellitus

Intervention

Other:
• Self-efficacy for diabetes management
Participants at both sites will watch a 12 minute video featuring the digital stories on diabetes. Following the video, participants will engage in a brief facilitated discussion regarding motivations and barriers to diabetes management, led by a trained Spanish-speaking facilitator.

Locations

Country	Name	City	State
United States	Mayo Clinic in Rochester	Rochester	Minnesota

Sponsors (1)

Lead Sponsor	Collaborator
Mayo Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Self-efficacy for diabetes management	The evaluation will assess the degree to which the intervention motivates the patient to improve self-management of diabetes. The evaluation will also assess overall acceptability. Items for this survey were adapted from a well validated health communication assessment tool produced by the National Cancer Institute.	Assessment will be done immediately after participants watch the intervention video